September 1, 2010

Microplasmin meets primary endpoint in second phase III trial in VMA, confirms positive findings of first trial.. more »

August 26, 2010

ThromboGenics announces 2010 first half results.. more »

July 15 2010

ThromboGenics announces publication of positive Microplasmin phase II data in the journal Retina.. more »

July 9 2010

Positive results from Phase II VTE Prophylaxis study with TB-402 presented at the 21st International Congress on Thrombosis in Milan, Italy... more »

July 1 2010

ThromboGenics to present results of second Phase III trial of microplasmin at the 28th Annual Meeting of the American Society of Retina Specialists (ASRS) and the 10th EURETINA Congress... more »

June 7 2010

ThromboGenics presents new exciting Microplasmin Phase III data at the World Ophthalmology Congress in Berlin... more »

June 4 2010

ThromboGenics to Present at the Jefferies 2010 Global Life Sciences Conference in New York on June 10... more »

May 17 2010

ThromboGenics and BioInvent to receive €10 million milestone as partner Roche begins new clinical study with TB-403... more »

May 11 2010

ThromboGenics' business update... more »

May 6, 2010

ThromboGenics and BioInvent announce positive topline results from Phase II VTE Prophylaxis study with anti-factor VIII... more »

April 20, 2010

ThromboGenics announces that microplasmin meets primary endpoint in Phase III Trial... more »

March 25, 2010

ThromboGenics raises 0,6 Million Euro from the exercise of warrants... more »

March 12, 2010

ThromboGenics announces business update and 2009 full year results... more »

February 9, 2010

ThromboGenics - Positive Microplasmin Phase II data published in Ophthalmology... more »